Transmax is the choice of top medical institutes for resveratrol studies

At the recent American Diabetes Association Science Conference in Orlando Florida, Albert Einstein Medical College presented the results of two human trials using resveratrol, a compound isolated from red grapes, called Biotivia Transmax, in place of Avandia.

Transmax, the particular type of resveratrol used in a number of human clinical trials over the past three years, performed extraordinarily well in lowering blood glucose, improving glucose tolerance, increasing insulin sensitivity and enhancing mitochondrial function in pre-diabetic patients, all with no adverse effects or toxicity.

Albert Einstein Medical College was recently awarded a grant by the NIH to expand the trial with a larger subject base over a longer period of treatment in collaboration with the Mayo Clinic. It may be time this safe and reasonably cheap natural compound be taken seriously by all type 2 diabetes sufferers.